Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia
- PMID: 8077318
- DOI: 10.1210/jcem.77.5.8077318
Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia
Abstract
We report pubertal maturation and dynamic studies of gonadotropin and gonadal hormone secretion in long term glucocorticoid-treated siblings with nonsalt-wasting classic adrenal and gonadal 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) deficiency. The 18-yr-old female siblings spontaneously developed thelarche and menarche at 10 and 12 yr, respectively, and manifested irregular menses, hirsutism, and polycystic ovaries at 17 yr. The 16-yr-old male sibling spontaneously developed secondary sex characteristics at age 11 yr and exhibited Tanner IV-V pubic hair, a 6.5 x 3.0-cm surgically repaired penis, and enlarged nonnodular testes. Overnight (2200-0700 h) plasma gonadotropin (every 20 min) and gonadal steroid levels (every 2 h) under ACTH adrenal suppression revealed the following. In the male sibling, there were overall normal Tanner V male LH (3-21 mIU/mL) and FSH (1.2-13 mIU/mL) levels, normal peak frequency and amplitude of LH (70 +/- 62 min and 15 +/- 3 mIU/mL, respectively) and FSH (65 +/- 28 min and 13 +/- 3 mIU/mL), and low normal Tanner V testosterone (T) levels (11.4-17.9 nmol/L). In the female sibling, there were normal follicular phase range LH (10-28 mIU/mL) and FSH (5.1-17.2 mIU/mL) levels, normal peak frequency and amplitude of LH (96 +/- 17 min and 22 +/- 4.5 mIU/mL, respectively) and FSH (62 +/- 27 min, 13 +/- 4 mIU/mL), and early follicular phase estradiol (E2) levels (100-170 pmol/L). The LH-releasing hormone-stimulated LH response was in the normal adult range in the male and normal for the early follicular phase in the female. In contrast, ACTH and adrenal delta 5-steroid responses to CRH administration were elevated in each sibling. Gonadal suppression via Norlutin administration (30 mg/day for 3 days) after prolonged adrenal suppression by dexamethasone resulted in suppression of dehydroepiandrosterone (DHEA) and E2 in the female and DHEA and T in the male. Gonadal stimulation via hCG administration (5000 IU/day for 3 days, im) during continuous adrenal suppression resulted in a low E2 response in the female (200 pmol/L; control, 295-660 pmol/L) and a low T response in the male (15.3 nmol/L; control, 17-39 nmol/L), whereas delta 5-17-hydroxypregnenolone and DHEA levels rose 2- to 4.7-fold in each sibling. In conclusion, despite partial gonadal 3 beta HSD deficiency, the dynamics of gonadotropin and gonadal hormone secretion in these siblings indicate the absence of increased LH secretion, in contrast to the markedly increased ACTH secretion resulting from adrenal 3 beta HSD deficiency.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.J Clin Endocrinol Metab. 1983 Apr;56(4):808-18. doi: 10.1210/jcem-56-4-808. J Clin Endocrinol Metab. 1983. PMID: 6300166
-
Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency.J Clin Endocrinol Metab. 2002 Jun;87(6):2611-22. doi: 10.1210/jcem.87.6.8615. J Clin Endocrinol Metab. 2002. PMID: 12050224
-
Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels.J Clin Endocrinol Metab. 1996 Nov;81(11):3961-5. doi: 10.1210/jcem.81.11.8923844. J Clin Endocrinol Metab. 1996. PMID: 8923844
-
Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.Semin Reprod Med. 2002 Aug;20(3):255-76. doi: 10.1055/s-2002-35373. Semin Reprod Med. 2002. PMID: 12428206 Review.
-
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.Endocr Rev. 1986 Feb;7(1):24-33. doi: 10.1210/edrv-7-1-24. Endocr Rev. 1986. PMID: 2937629 Review.
Cited by
-
Human 3beta-hydroxysteroid dehydrogenase deficiency associated with normal spermatic numeration despite a severe enzyme deficit.Endocr Connect. 2018 Mar;7(3):395-402. doi: 10.1530/EC-17-0306. Epub 2018 Feb 2. Endocr Connect. 2018. PMID: 29420188 Free PMC article.
-
46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features.Int J Mol Sci. 2019 Sep 17;20(18):4605. doi: 10.3390/ijms20184605. Int J Mol Sci. 2019. PMID: 31533357 Free PMC article. Review.
-
Clinical and molecular review of atypical congenital adrenal hyperplasia.Ann Pediatr Endocrinol Metab. 2015 Mar;20(1):1-7. doi: 10.6065/apem.2015.20.1.1. Epub 2015 Mar 31. Ann Pediatr Endocrinol Metab. 2015. PMID: 25883920 Free PMC article. Review.
-
Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency.Endocrine. 2019 Mar;63(3):407-421. doi: 10.1007/s12020-018-01835-3. Epub 2019 Feb 4. Endocrine. 2019. PMID: 30719691 Free PMC article. Review.
-
The molecular basis and genotype-phenotype correlations of congenital adrenal hyperplasia (CAH) in Anatolian population.Mol Biol Rep. 2019 Aug;46(4):3677-3690. doi: 10.1007/s11033-019-04809-4. Epub 2019 Apr 20. Mol Biol Rep. 2019. PMID: 31006099
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical